Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Incidence of Respiratory Syncytial Virus Infection in Older Adults: Limitations of Current Data
Mark H. Rozenbaum, Elizabeth Begier, Samantha K. Kurosky, et al.
Infectious Diseases and Therapy (2023) Vol. 12, Iss. 6, pp. 1487-1504
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults
Christine A. Shaw, Brandon Essink, Charles Harper, et al.
The Journal of Infectious Diseases (2024) Vol. 230, Iss. 3, pp. e647-e656
Open Access | Times Cited: 25
Estimated Incidence of Hospitalizations and Deaths Attributable to Respiratory Syncytial Virus Infections Among Adults in Germany Between 2015 and 2019
Aleksandra Polkowska-Kramek, Elizabeth Begier, Robin Bruyndonckx, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 4, pp. 845-860
Open Access | Times Cited: 18
The recent landscape of RSV vaccine research
Karen Kelleher, N. Subramaniam, Simon B. Drysdale
Therapeutic Advances in Vaccines and Immunotherapy (2025) Vol. 13
Open Access | Times Cited: 3
Exploring case definitions and the natural history of respiratory syncytial virus in adult outpatients: First-season results of the RESPIRA-50 study
Alexander Domnich, Francesco Lapi, Andrea Orsi, et al.
Journal of Infection and Public Health (2025) Vol. 18, Iss. 3, pp. 102653-102653
Open Access | Times Cited: 2
Detection of RSV using nasopharyngeal swabs alone underestimates RSV-related hospitalization incidence in adults: the Multispecimen study's Final Analysis
Elizabeth Begier, Negar Aliabadi, Julio A. Ramírez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 2
Epidemiology and burden of respiratory syncytial virus in Italian adults: A systematic review and meta-analysis
Alexander Domnich, Giovanna Elisa Calabrò
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0297608-e0297608
Open Access | Times Cited: 13
Would senior citizens get vaccinated against RSV? Exploratory analysis using a novel survey instrument
Mohammad Abu-Ghosh, D. Saleh, Joud Al-Haddad, et al.
Vacunas (2025) Vol. 26, Iss. 1, pp. 100384-100384
Open Access | Times Cited: 1
Understanding the Burden of Respiratory Syncytial Virus in Older Adults in Latin America: An Expert Perspective on Knowledge Gaps
Ricardo de Amorim Corrêa, Francisco Arancibia, Renato de Ávila Kfouri, et al.
Pulmonary Therapy (2024) Vol. 10, Iss. 1, pp. 1-20
Open Access | Times Cited: 8
Estimation of Symptomatic Respiratory Syncytial Virus Infection Incidence in Adults in Multiple Countries: A Time-Series Model-Based Analysis Protocol
Robin Bruyndonckx, Aleksandra Polkowska-Kramek, Caihua Liang, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 4, pp. 953-963
Open Access | Times Cited: 8
From Forgotten Pathogen to Target for New Vaccines: What Clinicians Need to Know about Respiratory Syncytial Virus Infection in Older Adults
Matteo Boattini, André Almeida, Sara Comini, et al.
Viruses (2024) Vol. 16, Iss. 4, pp. 531-531
Open Access | Times Cited: 8
Vaccines for the Elderly and Vaccination Programs in Europe and the United States
Cleo Anastassopoulou, Stefanos Ferous, Snežana Medić, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 566-566
Open Access | Times Cited: 7
Influenza-like illness surveillance may underestimate the incidence of respiratory syncytial virus in adult outpatients
Alexander Domnich, Andrea Orsi, Matilde Ogliastro, et al.
International Journal of Infectious Diseases (2024) Vol. 141, pp. 106968-106968
Open Access | Times Cited: 6
Respiratory syncytial virus: challenges in diagnosis and impact on the elderly: Recommendations from a multidisciplinary panel
Lessandra Michelin, Nancy Bellei, Marcelo Ferreira da Costa Gomes, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 6
Epidemiology and burden of respiratory syncytial virus in Italian adults: A systematic review and meta-analysis
Alexander Domnich, Giovanna Elisa Calabrò
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 5
Randomized, Open-Label Phase 3 Study Evaluating Immunogenicity, Safety, and Reactogenicity of RSVPreF3 OA Coadministered with FLU-QIV-HD in Adults Aged ≥ 65
Robert Buynak, Kevin D. Cannon, David DeAtkine, et al.
Infectious Diseases and Therapy (2024) Vol. 13, Iss. 8, pp. 1789-1805
Open Access | Times Cited: 5
Burden of Respiratory Syncytial Virus–Associated Acute Respiratory Infections During Pregnancy
Sébastien Kenmoe, Helen Y. Chu, Fatimah S. Dawood, et al.
The Journal of Infectious Diseases (2023) Vol. 229, Iss. Supplement_1, pp. S51-S60
Open Access | Times Cited: 11
Severe respiratory syncytial virus disease
Yolanda Peña-López, Joan Sabater‐Riera, Prithvi Raj
Journal of Intensive Medicine (2024) Vol. 4, Iss. 4, pp. 405-416
Open Access | Times Cited: 4
Respiratory Syncytial Virus-Attributable Hospitalizations Among Adults in High- and Middle-Income Countries: Application of the Global Burden of Disease Framework
Katrin Burkart, Quinn Rafferty, Catherine W. Gillespie, et al.
(2025)
Closed Access
Incidence of RSV-related Hospitalizations for ARIs, including CAP: Data from the German Prospective ThEpiCAP Study
Caihua Liang, Elizabeth Begier, Stefan Hagel, et al.
Journal of Infection (2025), pp. 106440-106440
Open Access
Enhanced Safety Surveillance of the Adjuvanted Respiratory Syncytial Virus Vaccine Among Italian Older Adults
Alexander Domnich, Andrea Orsi, Piero Luigi Lai, et al.
(2025)
Closed Access
“Insights in the RSV L polymerase function and structure”
Brecht Bonneux, Martina Ceconi, Kim Stobbelaar, et al.
Antiviral Research (2025), pp. 106148-106148
Closed Access
Immunogenicity Evaluation of Combination Respiratory Syncytial Virus and Varicella–Zoster Virus mRNA Vaccines in C57BL/6J Mice
Ning Luan, L Huang, Jingping Hu, et al.
Vaccines (2025) Vol. 13, Iss. 4, pp. 361-361
Open Access
Would senior citizens get vaccinated against RSV? Exploratory analysis using a novel survey instrument
Mohammad Abu-Ghosh, D. Saleh, Joud Al-Haddad, et al.
Vacunas (English Edition) (2025) Vol. 26, Iss. 1, pp. 100384-100384
Open Access
A Phase 2a, Randomized, Placebo-Controlled Human Challenge Trial to Evaluate the Efficacy and Safety of Molnupiravir in Healthy Participants Inoculated with Respiratory Syncytial Virus
Mickie Cheng, Alex Mann, Brian M. Maas, et al.
Pulmonary Therapy (2025)
Open Access
Estimated Incidence of Hospitalisations and Deaths Attributable to Respiratory Syncytial Virus Infections in Adults in Australia Between 2010 and 2019
Z. Wiid, Caihua Liang, Robin Bruyndonckx, et al.
Influenza and Other Respiratory Viruses (2025) Vol. 19, Iss. 4
Open Access
Page 1 - Next Page

Scroll to top